| 摘要 |
This invention concerns a test method for the purposes of diagnosis, prognosis or therapeutic monitoring in male patients with adenocarcinoma of the prostate or benign prostatic hyperplasia, which does not require a biopsy of prostate tissue, and which exploits the combination of at least one tissue-specific marker and at least one marker for inflammation in order to arrive at a diagnosis. The invention also concerns a process using such a method, an immunological test to implement such a process, and a diagnostic kit. The invention is applied to the diagnosis of adenocarcinoma of the prostate and benign prostatic hyperplasia.
|
